Glycolysis-enhancing α1-adrenergic antagonists modify cognitive symptoms related to Parkinson’s disease
View ORCID ProfileMatthew A. Weber, Kartik Sivakumar, Ervina E. Tabakovic, Mayu Oya, Georgina M. Aldridge, View ORCID ProfileQiang Zhang, View ORCID ProfileJacob E. Simmering, View ORCID ProfileNandakumar S. Narayanan
doi: https://doi.org/10.1101/2022.07.01.22277111
Matthew A. Weber
1Department of Neurology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City
PhDKartik Sivakumar
1Department of Neurology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City
Ervina E. Tabakovic
1Department of Neurology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City
Mayu Oya
1Department of Neurology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City
Georgina M. Aldridge
1Department of Neurology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City
MD, PhDQiang Zhang
1Department of Neurology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City
MDJacob E. Simmering
2Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City
PhDNandakumar S. Narayanan
1Department of Neurology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City
MD, PhDData Availability
All data relevant to the human Truven database produced in the present study are available upon reasonable request to the authors. All animal data produced are available online at: https://narayanan.lab.uiowa.edu/article/datasets
Posted July 02, 2022.
Glycolysis-enhancing α1-adrenergic antagonists modify cognitive symptoms related to Parkinson’s disease
Matthew A. Weber, Kartik Sivakumar, Ervina E. Tabakovic, Mayu Oya, Georgina M. Aldridge, Qiang Zhang, Jacob E. Simmering, Nandakumar S. Narayanan
medRxiv 2022.07.01.22277111; doi: https://doi.org/10.1101/2022.07.01.22277111
Glycolysis-enhancing α1-adrenergic antagonists modify cognitive symptoms related to Parkinson’s disease
Matthew A. Weber, Kartik Sivakumar, Ervina E. Tabakovic, Mayu Oya, Georgina M. Aldridge, Qiang Zhang, Jacob E. Simmering, Nandakumar S. Narayanan
medRxiv 2022.07.01.22277111; doi: https://doi.org/10.1101/2022.07.01.22277111
Subject Area
Subject Areas
- Addiction Medicine (353)
- Allergy and Immunology (675)
- Anesthesia (181)
- Cardiovascular Medicine (2672)
- Dermatology (226)
- Emergency Medicine (404)
- Epidemiology (12290)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4143)
- Geriatric Medicine (388)
- Health Economics (682)
- Health Informatics (2684)
- Health Policy (1008)
- Hematology (365)
- HIV/AIDS (857)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (443)
- Neurology (3924)
- Nursing (212)
- Nutrition (584)
- Oncology (2063)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (306)
- Pain Medicine (251)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1125)
- Primary Care Research (459)
- Public and Global Health (6562)
- Radiology and Imaging (1413)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (454)
- Toxicology (54)
- Transplantation (189)
- Urology (169)